{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:40:18Z","timestamp":1791099618262,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":5428,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.nurt.2008.08.004","type":"journal-article","created":{"date-parts":[[2008,10,4]],"date-time":"2008-10-04T15:11:21Z","timestamp":1223133081000},"page":"613-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Therapy of Collagen VI-Related Myopathies (Bethlem and Ullrich)"],"prefix":"10.1016","volume":"5","author":[{"given":"Luciano","family":"Merlini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nurt.2008.08.004_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/brain\/99.1.91","article-title":"Benign myopathy, with autosomal dominant inheritance: a report on three pedigrees","volume":"99","author":"Bethlem","year":"1976","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2008.08.004_bib2","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1073\/pnas.121027598","article-title":"Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI","volume":"98","author":"Camacho Vanegas","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.08.004_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1212\/WNL.58.4.593","article-title":"Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype","volume":"58","author":"Scacheri","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.004_bib4","doi-asserted-by":"crossref","DOI":"10.1212\/01.wnl.0000327611.01687.5e","article-title":"Autosomal recessive myosclerosis myopathy is a collagen VI disorder","author":"Merlini","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.004_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0960-8966(94)90091-4","article-title":"Bethlem myopathy: early-onset benign autosomal dominant myopathy with contractures: description of two new families","volume":"4","author":"Merlini","year":"1994","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.08.004_bib6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1006\/bbrc.1999.0680","article-title":"A heterozygous splice site mutation in COL6A1 leading to an in-frame deletion of the \u03b11(VI) collagen chain in an Italian family affected by Bethlem myopathy","volume":"258","author":"Pepe","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nurt.2008.08.004_bib7","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archneur.63.11.1617","article-title":"Cardiac and pulmonary investigations in Bethlem myopathy","volume":"63","author":"van der Kooi","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2008.08.004_bib8","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0960-8966(02)00139-6","article-title":"Bethlem myopathy (BETHLEM) and Ullrich scleroatonic muscular dystrophy: 100th ENMC international workshop, 23\u201324 November 2001, Naarden, The Netherlands","volume":"12","author":"Pepe","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.08.004_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1086\/377107","article-title":"New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype","volume":"73","author":"Pan","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nurt.2008.08.004_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/hmg\/ddi025","article-title":"Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy","volume":"14","author":"Baker","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.08.004_bib11","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1086\/340608","article-title":"Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy","volume":"70","author":"Demir","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nurt.2008.08.004_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/jmg.2004.023754","article-title":"Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy","volume":"42","author":"Lampe","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.nurt.2008.08.004_bib13","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.WNL.0000163990.00057.66","article-title":"Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy","volume":"64","author":"Lucioli","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.004_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jmg.2002.002311","article-title":"Collagen VI related muscle disorders","volume":"42","author":"Lampe","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.nurt.2008.08.004_bib15","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.1074\/jbc.M709540200","article-title":"Three novel collagen VI chains with high homology to the \u03b13 chain","volume":"283","author":"Gara","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.08.004_bib16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0960-8966(99)00022-X","article-title":"Decreased expression of laminin \u03b21 in chromosome 21-linked Bethlem myopathy","volume":"9","author":"Merlini","year":"1999","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.08.004_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0960-8966(02)00282-1","article-title":"Pathological characteristics of skeletal muscle in Ullrich's disease with collagen VI deficiency","volume":"13","author":"Higuchi","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.08.004_bib18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.nmd.2006.07.015","article-title":"A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations","volume":"16","author":"Jimenez-Mallebrera","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.08.004_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/nen.0b013e3181634ef7","article-title":"Muscle interstitial fibroblasts are the main source of collagen VI synthesis in skeletal muscle: implications for congenital muscular dystrophy types Ullrich and Bethlem","author":"Zou","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nurt.2008.08.004_bib20","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1212\/01.wnl.0000307749.66438.6d","article-title":"A refined diagnostic algorithm for Bethlem myopathy","volume":"70","author":"Hicks","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.004_bib21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1469-8749.1989.tb04029.x","article-title":"Scoliosis in spinal muscular atrophy: natural history and management","volume":"31","author":"Merlini","year":"1989","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nurt.2008.08.004_bib22","first-page":"175","article-title":"Treatment of scoliosis in intermediate spinal muscular atrophy (SMA type II) in childhood","volume":"7","author":"Fujak","year":"2005","journal-title":"Ortop Traumatol Rehabil"},{"key":"10.1016\/j.nurt.2008.08.004_bib23","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.2106\/00004623-200409000-00014","article-title":"Anterior release of the elbow for extension loss","volume":"86A","author":"Aldridge","year":"2004","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.nurt.2008.08.004_bib24","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.arthro.2006.04.100","article-title":"Functional outcomes of arthroscopic capsular release of the elbow","volume":"22","author":"Nguyen","year":"2006","journal-title":"Arthroscopy"},{"key":"10.1016\/j.nurt.2008.08.004_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nmd.2003.09.003","article-title":"117th ENMC workshop: ventilatory support in congenital neuromuscular disorders: congenital myopathies, congenital muscular dystrophies, congenital myotonic dystrophy and SMA (II) 4\u20136 April 2003, Naarden, The Netherlands","volume":"14","author":"Wallgren-Pettersson","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.08.004_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.matbio.2007.02.004","article-title":"A therapy for myopathy caused by collagen VI mutations?","volume":"26","author":"Hohenester","year":"2007","journal-title":"Matrix Biol"},{"key":"10.1016\/j.nurt.2008.08.004_bib27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng1270","article-title":"Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency","volume":"35","author":"Irwin","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.nurt.2008.08.004_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0968-0004(00)01745-X","article-title":"A mitochondrial perspective on cell death","volume":"26","author":"Bernardi","year":"2001","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.nurt.2008.08.004_bib29","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/434578a","article-title":"Biochemistry: a pore way to die","volume":"434","author":"Halestrap","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.nurt.2008.08.004_bib30","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/hmg\/7.13.2135","article-title":"Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy","volume":"7","author":"Bonaldo","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.08.004_bib31","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1073\/pnas.0610270104","article-title":"Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins","volume":"104","author":"Angelin","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.08.004_bib32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ng1203-300","article-title":"The collagen\u2013mitochondria connection","volume":"35","author":"Rizzuto","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.nurt.2008.08.004_bib33","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1073\/pnas.0800962105","article-title":"Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies","volume":"105","author":"Merlini","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.08.004_bib34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ymthe.2006.04.011","article-title":"Specific inhibition of nonsense-mediated mRNA decay components, SMG-1 or Upf1, rescues the phenotype of Ullrich disease fibroblasts","volume":"14","author":"Usuki","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.nurt.2008.08.004_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1212\/01.WNL.0000148485.00049.B7","article-title":"Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society","volume":"64","author":"Moxley","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.004_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0960-8966(01)00272-3","article-title":"90th ENMC international workshop: European Spinal Muscular Atrophy Randomised Trial (EuroSMART) 9\u201310 February 2001, Naarden, The Netherlands","volume":"12","author":"Merlini","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.08.004_bib37","first-page":"82","article-title":"Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy","volume":"106","author":"van der Beek","year":"2006","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.nurt.2008.08.004_bib38","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1056\/NEJMoa073108","article-title":"Local dystrophin restoration with antisense oligonucleotide PRO051","volume":"357","author":"van Deutekom","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2008.08.004_bib39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/107327480701400209","article-title":"Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design","volume":"14","author":"Behera","year":"2007","journal-title":"Cancer Control"},{"key":"10.1016\/j.nurt.2008.08.004_bib40","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/bmj.311.7020.1621","article-title":"Clinical trials and rare diseases: a way out of a conundrum","volume":"311","author":"Lilford","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.nurt.2008.08.004_bib42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/pmic.200500098","article-title":"Proteomic investigation of the molecular pathophysiology of dysferlinopathy","volume":"6","author":"De Palma","year":"2006","journal-title":"Proteomics"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923004580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923004580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurt.2008.08.004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:38:05Z","timestamp":1761806285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923004580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1878747923004580"],"URL":"https:\/\/doi.org\/10.1016\/j.nurt.2008.08.004","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapy of Collagen VI-Related Myopathies (Bethlem and Ullrich)","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurt.2008.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}